Anaplastic lymphoma kinase (ALK) gene rearrangement is present in approximately 50% of inflammatory myofibroblastic tumors (IMTs), which are rare mesenchymal tumors primarily affecting pediatric and adolescent populations. Here, ALK is linked to inflammatory myofibroblastic tumor.